Therefore, it is important to further clarify the biological functions of ATF3 in different stages of adipocyte development in obesity, which will be more conducive to the development of intervention strategies for metabolic diseases based on targeting ATF3 in the future. This evidence concerns the gene ATF3 and Other metabolic disease.